MYR 4.29
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 116.89 Million MYR | -1.68% |
2022 | 118.89 Million MYR | 15.85% |
2021 | 102.63 Million MYR | 10.11% |
2020 | 93.2 Million MYR | -10.46% |
2019 | 104.09 Million MYR | 0.02% |
2018 | 104.06 Million MYR | -2.8% |
2017 | 107.06 Million MYR | 2.14% |
2016 | 104.82 Million MYR | 4.43% |
2015 | 100.37 Million MYR | -1.59% |
2014 | 101.99 Million MYR | 9.76% |
2013 | 92.92 Million MYR | 14.84% |
2012 | 80.91 Million MYR | 5.71% |
2011 | 76.54 Million MYR | 6.77% |
2010 | 71.69 Million MYR | 28.87% |
2009 | 55.63 Million MYR | 14.59% |
2008 | 48.54 Million MYR | -5.91% |
2007 | 51.59 Million MYR | 13.57% |
2006 | 45.43 Million MYR | 26.06% |
2005 | 36.04 Million MYR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q4 | -10.12 Million MYR | -254.59% |
2023 Q3 | -2.85 Million MYR | -106.25% |
2023 FY | -7.98 Million MYR | -106.71% |
2023 Q2 | 45.65 Million MYR | 15.9% |
2023 Q1 | 39.39 Million MYR | 367.21% |
2022 Q1 | 46.34 Million MYR | 553.7% |
2022 Q2 | 45.65 Million MYR | -1.49% |
2022 Q3 | 41.64 Million MYR | -8.77% |
2022 Q4 | -14.74 Million MYR | -135.4% |
2022 FY | 118.89 Million MYR | 15.85% |
2021 Q1 | 36.02 Million MYR | 450.67% |
2021 Q3 | 38.02 Million MYR | -1.97% |
2021 Q4 | -10.21 Million MYR | -126.86% |
2021 FY | 102.63 Million MYR | 10.11% |
2021 Q2 | 38.79 Million MYR | 7.7% |
2020 Q1 | 31.86 Million MYR | 505.96% |
2020 Q3 | 36.9 Million MYR | 6.3% |
2020 FY | 93.2 Million MYR | -10.46% |
2020 Q4 | -10.27 Million MYR | -127.84% |
2020 Q2 | 34.71 Million MYR | 8.96% |
2019 Q4 | -7.84 Million MYR | -120.4% |
2019 FY | 104.09 Million MYR | 0.02% |
2019 Q3 | 38.46 Million MYR | -2.59% |
2019 Q1 | 33.98 Million MYR | 409.14% |
2019 Q2 | 39.49 Million MYR | 16.2% |
2018 Q2 | 39.46 Million MYR | -3.02% |
2018 FY | 104.06 Million MYR | -2.8% |
2018 Q4 | -10.99 Million MYR | -131.49% |
2018 Q3 | 34.9 Million MYR | -11.55% |
2018 Q1 | 40.69 Million MYR | 411.02% |
2017 Q3 | 39.61 Million MYR | -3.22% |
2017 Q2 | 40.93 Million MYR | 3.36% |
2017 FY | 107.06 Million MYR | 2.14% |
2017 Q1 | 39.6 Million MYR | 1008.53% |
2017 Q4 | -13.08 Million MYR | -133.03% |
2016 Q3 | 39.17 Million MYR | 3.54% |
2016 FY | 104.82 Million MYR | 4.43% |
2016 Q4 | -4.35 Million MYR | -111.13% |
2016 Q2 | 37.83 Million MYR | 17.61% |
2016 Q1 | 32.16 Million MYR | 465.1% |
2015 Q2 | 36.99 Million MYR | 14.42% |
2015 Q1 | 32.33 Million MYR | 2702.08% |
2015 Q3 | 39.84 Million MYR | 7.7% |
2015 Q4 | -8.81 Million MYR | -122.11% |
2015 FY | 100.37 Million MYR | -1.59% |
2014 Q4 | 1.15 Million MYR | -96.48% |
2014 Q3 | 32.77 Million MYR | -6.71% |
2014 FY | 101.99 Million MYR | 9.76% |
2014 Q2 | 35.13 Million MYR | 6.71% |
2014 Q1 | 32.92 Million MYR | 1050.52% |
2013 Q2 | 33.46 Million MYR | 23.36% |
2013 Q3 | 35.79 Million MYR | 6.95% |
2013 Q4 | -3.46 Million MYR | -109.68% |
2013 FY | 92.92 Million MYR | 14.84% |
2013 Q1 | 27.12 Million MYR | 694.41% |
2012 Q3 | 31.86 Million MYR | 12.13% |
2012 FY | 80.91 Million MYR | 5.71% |
2012 Q1 | 25.2 Million MYR | 456.06% |
2012 Q4 | -4.56 Million MYR | -114.32% |
2012 Q2 | 28.41 Million MYR | 12.75% |
2011 Q1 | 25.84 Million MYR | 428.04% |
2011 Q2 | 30 Million MYR | 16.1% |
2011 Q4 | -7.07 Million MYR | -125.48% |
2011 FY | 76.54 Million MYR | 6.77% |
2011 Q3 | 27.78 Million MYR | -7.39% |
2010 FY | 71.69 Million MYR | 28.87% |
2010 Q2 | 28.42 Million MYR | 0.0% |
2010 Q3 | 27.17 Million MYR | -4.4% |
2010 Q4 | -7.87 Million MYR | -128.99% |
2009 Q4 | -8.15 Million MYR | -135.61% |
2009 Q3 | 22.91 Million MYR | 0.0% |
2009 FY | 55.63 Million MYR | 14.59% |
2008 FY | 48.54 Million MYR | -5.91% |
2007 FY | 51.59 Million MYR | 13.57% |
2006 FY | 45.43 Million MYR | 26.06% |
2005 FY | 36.04 Million MYR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Duopharma Biotech Berhad | 187.45 Million MYR | 37.643% |